Meta-Analysis:
Dietary fat intake and risk of esophageal carcinoma: a meta-analysis of observational studies
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1455 views | HTML 2220 views | ?
Abstract
Du He1,2,*, Xue Huang1,2,*, Zai-Ping Wang1,2,*, Dian Chen1,2, Jun Chen1,2 and Chun-Yan Duan1,2
1Department of Oncology, The Central Hospital of Enshi Autonomous Prefecture, Enshi 445000, China
2Enshi Clinical College of Wuhan University, Enshi 445000, China
*These authors contributed equally to this work
Correspondence to:
Jun Chen, email: [email protected]
Chun-Yan Duan, email: [email protected]
Keywords: fat intake, esophageal carcinoma, risk, meta-analysis
Received: May 27, 2017 Accepted: September 21, 2017 Published: October 03, 2017
ABSTRACT
Dietary fat intake is potentially associated with the onset of esophageal carcinoma (EC), but evidence from observational studies has remained unclear. This study aimed to evaluate the role of fat intake in the development of esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). A systematic search was conducted in PubMed and Web of Science to identify all relevant studies. Study-specific relative risks (RR) for the highest versus the lowest intake categories and 95% confidence intervals (CI) were pooled using a random-effects model. Seventeen case-control studies (2058 EAC cases, 1581 ESCC cases and 11696 controls) and two prospective cohort studies (494, 978 participants and 630 EAC cases and 215 ESCC cases) were identified. In EAC, the RRs (95% CI) were 1.69 (1.14–2.50) for total fat intake, 1.88 (1.28–2.77) for saturated fat (SFA) intake, 1.04 (0.86–1.27) for polyunsaturated fat (PUFA) intake and 1.70 (1.01–2.84) for monounsaturated fat (MUFA) intake. In ESCC, the RRs (95% CI) were 1.12 (0.84–1.51) for total fat, 1.38 (0.91–2.08) for SFA, 0.95 (0.55–1.62) for PUFA and 1.04 (0.65–1.66) for MUFA. In conclusion, total fat, SFA and MUFA intake were associated with EAC risk, but fat intake showed no significant association with ESCC risk. Large-scale prospective cohort studies are needed to confirm our findings.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21462